Opko Health Appoints Dr. Benjamin Solomon As Managing Director Of GeneDx
MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NASDAQ:OPK), announces the appointment of Benjamin D. Solomon, M.D. as Managing Director of GeneDx, effective as of October 3, 2016. GeneDx, part of OPKO’s BioReference Laboratories subsidiary, specializes in genetic testing for rare hereditary disorders.
Dr. Solomon is a pediatric geneticist who focuses on the use of genetics and genomics to identify, understand and care for patients with both rare and common genetic conditions. He is a leader in integrating cutting-edge technologies to better manage health and disease. He most recently served as Chief of the Division of Medical Genomics at the Inova Translational Medicine Institute, a clinical research institute dedicated to putting genomic medicine into action.
Dr. Solomon is a pediatric geneticist who focuses on the use of genetics and genomics to identify, understand and care for patients with both rare and common genetic conditions. He is a leader in integrating cutting-edge technologies to better manage health and disease. He most recently served as Chief of the Division of Medical Genomics at the Inova Translational Medicine Institute, a clinical research institute dedicated to putting genomic medicine into action.